ARCH THERAPEUTICS
Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients.
ARCH THERAPEUTICS
Industry:
Biotechnology Health Care Medical Device
Founded:
2006-01-01
Address:
Natick, Massachusetts, United States
Country:
United States
Website Url:
http://www.archtherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
1 617.475.5254
Total Funding:
27.05 M USD
Technology used in webpage:
Google Maps Thickbox
Similar Organizations
Sesen Bio, Inc.
Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
Eliaz Therapeutics
Eliaz Therapeutics is developing a novel treatment using targeted therapeutic apheresis to remove Galetin-3 from the body
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
InVivo Therapeutics
InVivo Therapeutics is a medical device company focused on developing restoration treatments for patients with spinal cord-injuries.
Micell Technologies
Micell Technologies is a biomedical device company developing interventional cardiology systems for vascular drug delivery.
Probo Medical
Probo Medical is a medical devices company offering ultrasound probes and ultrasound systems.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
RxSight
RxSight is a medical device company that offers an intraocular lens and cataract surgery solutions.
Tandem Diabetes Care
Tandem diabetes care provides products that empower both people with diabetes and those who care for them.
Urotronic
Urotronic is a medical device company that develops a drug-coated balloon device for interventional urology.
Current Employees Featured
Richard E. Davis Chief Financial Officer @ Arch Therapeutics
Chief Financial Officer
2014-04-01
Rutledge Ellis-Behnke Co-Founder & Scientific Advisor @ Arch Therapeutics
Co-Founder & Scientific Advisor
2004-09-01
Terrence W. Norchi President, CEO, Director, Co-Founder @ Arch Therapeutics
President, CEO, Director, Co-Founder
Steven A. Kates Consultant @ Arch Therapeutics
Consultant
Founder
Stock Details
Official Site Inspections
http://www.archtherapeutics.com Semrush global rank: 9.76 M Semrush visits lastest month: 320
- Host name: ec2-34-226-83-0.compute-1.amazonaws.com
- IP address: 34.226.83.0
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Arch Therapeutics"
Arch Therapeutics (ARTHQ) Company Profile & Description - Stock …
4 days ago Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self …See details»
Arch Therapeutics - Overview, News & Similar companies
May 6, 2024 Arch Therapeutics contact info: Phone number: (617) 431-2313 Website: www.archtherapeutics.com What does Arch Therapeutics do? Established in 2008 and based …See details»
Arch Therapeutics - Craft
Arch Therapeutics is a biotechnology company developing an innovative, elegant, and superior approach to the rapid cessation of bleeding (hemostasis) and control of fluid leakage (sealant) …See details»
Arch Therapeutics, Inc (OTCQB:ARTH) | LinkedIn
Arch Therapeutics, Inc. (OTCQB:ARTH) is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during …See details»
Press Releases :: Arch Therapeutics, Inc. (ARTH)
Jul 12, 2021 Dan is an outstanding addition to the organization, and I am confident he will provide strong leadership and results.” ... Email: investors@archtherapeutics.com Website: …See details»
Arch Therapeutics Company Profile | Management and Employees …
Www.archtherapeutics.com Arch Therapeutics Profile and History Established in 2008 and based out of Framingham, Massachusetts, Arch Therapeutics is a biotechnology company …See details»
Arch Therapeutics - Products, Competitors, Financials, Employees ...
Headquarters Location. 235 Walnut Street Suite 6. Framingham, Massachusetts, 01702, United States. 855-340-2784See details»
Overview :: Arch Therapeutics, Inc. (ARTH)
Contact Us. 235 Walnut Street, Suite 6 Framingham, MA 01702 Phone: +1-855-340-2784See details»
ARTH - Arch Therapeutics Inc Latest Stock News & Market Updates
Oct 1, 2024 For Investor Relations, contact Arch Therapeutics at +1-855-340-ARTH (2784) for US and Canada, or email at investors@archtherapeutics.com. Who is the Chief Financial …See details»
Arch Therapeutics - WoundSource
Arch Therapeutics is developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care using a self …See details»
Arch Therapeutics - Crunchbase Company Profile & Funding
Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and …See details»
Contact :: Arch Therapeutics, Inc. (ARTH)
Arch Therapeutics, Inc. 235 Walnut Street Suite 6 Framingham, MA 01702. Ordering Information. Click Here. Customer Service and Sales. Phone: +1-800-937-9030Email: …See details»
Arch Therapeutics Provides Corporate Update - GlobeNewswire
Oct 13, 2021 90-Day Report Card for Commercialization Effort FRAMINGHAM, Mass., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or...See details»
Press Releases :: Arch Therapeutics, Inc. (ARTH)
Medical Industry Veteran with Proven Track Record to Drive Commercialization Effort. FRAMINGHAM, Mass., July 12, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. …See details»
Leadership :: Arch Therapeutics, Inc. (ARTH)
Mr. Carlson joined Arch Therapeutics as Director of Sales in 2021 and was promoted to Vice President of Sales in December, 2023. He has over 20 years of medical device leadership …See details»
Arch Therapeutics Announces $6.9 Million Private Placement
FRAMINGHAM, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and …See details»
Corporate Mission :: Arch Therapeutics, Inc. (ARTH)
Contact Us. 235 Walnut Street, Suite 6 Framingham, MA 01702 Phone: +1-855-340-2784See details»
Press Releases :: Arch Therapeutics, Inc. (ARTH)
Email: investors@archtherapeutics.com Website: www.archtherapeutics.com. or. Michael Abrams Chief Financial Officer Arch Therapeutics, Inc. Phone: 617-431-2333 Email: …See details»
Pipeline :: Arch Therapeutics, Inc. (ARTH)
Contact Us. 235 Walnut Street, Suite 6 Framingham, MA 01702 Phone: +1-855-340-2784See details»
Press Releases :: Arch Therapeutics, Inc. (ARTH)
Company Completes a Critical Step in Its Progress Toward Commercialization of AC5. FRAMINGHAM, MA -- (Marketwired) -- 03/09/16 -- Arch Therapeutics, Inc. (OTCQB: ARTH) …See details»